Current medical research and opinionHumansHyperkalemiaMaleFemaleMiddle Aged
Real-world insights into hyperkalemia burden and RAASi discontinuation: a cohort study.
Abdullah Hashim Almalki, Laila Fahd Sadagah, Reyan Hatem Merdad, Nourah Abdulaziz Alorainan, Salma Mohamed Abbas Quqandi, Muhjah Abdulhakim Bukhari, Fahad Ali Abdullah Dokhaikh
Published: 202510.1080/03007995.2025.2579422
Abstract
BACKGROUND: Hyperkalemia is a common and clinically significant complication among patients receiving renin-angiotensin-aldosterone system inhibitors (RAASi). Despite their well-established cardiovascular and renal benefits, RAASi use is often limite…
Preview only. Read the full abstract at the source